Media Archive

2018 | 2017 | 2016 | 2015

Press Release

REVOLUTION Medicines Raises $56 Million in Series B Financing

Redwood City, CA – April 24, 2018 – REVOLUTION Medicines, Inc., a drug discovery and development company focused on frontier cancer targets, today announced it has raised $56 million in a Series B financing to support its ongoing R&D programs…

Read more

Publication / Presentation

Press Release

Revolution Medicines Appoints Vincent Miller, M.D. to Board of Directors

Redwood City, CA –October 5, 2017 – REVOLUTION Medicines, Inc., a drug discovery and development company focused on frontier cancer targets, today announced the appointment of Vincent Miller, M.D., to its board of directors. Dr. Miller is a…

Read more

Press Release

Revolution Medicines Reports Discovery that May Expand Range of Clinically Actionable Cancer Mutations

Redwood City, CA –September 14, 2017 – REVOLUTION Medicines, Inc., a company focused on frontier cancer targets and drug discovery, today published a report entitled “Efficacy of SHP2 phosphatase inhibition in cancers with nucleotide-cycling…

Read more

Publication / Presentation

Efficacy of SHP2 phosphatase inhibition in cancers with nucleotide-cycling oncogenic RAS, RAS-GTP dependent oncogenic BRAF and NF1 loss

New research revealed an unexpected dependence of some cancer-causing forms of proteins in the RAS-MAP kinase pathway on the normal biochemical actions of SHP2.  These functions can be disrupted by small molecule inhibitors of SHP2 designed by…

Read more

Press Release

Revolution Medicines Appoints Cancer Leader Dr. Stephen Kelsey as President of Research and Development

Redwood City, CA –March 20, 2017 – REVOLUTION Medicines, Inc., a company focused on frontier cancer targets and drug discovery inspired by nature’s lessons, today announced the appointment of Stephen (Steve) Kelsey, M.D., an…

Read more

Press Release

Revolution Medicines Raises Additional $25 Million in Series A Financing

Redwood City, Calif. – December 20, 2016 – REVOLUTION Medicines, Inc., a company focused on frontier cancer targets and drug discovery inspired by nature’s lessons, today announced that it has raised $25 million in a Series A extension financing…

Read more

Press Release

Revolution Medicines Names Distinguished Cancer Scientists and Drug Hunters to Senior Advisory Roles

Redwood City, CA – December 13, 2016 – REVOLUTION Medicines, Inc., a company focused on frontier cancer targets and drug discovery inspired by nature’s lessons, today announced that noted chemical biologist and cancer…

Read more

Press Release

Revolution Medicines Names Academic Co-Founder, Michael Fischbach, Ph.D., and Senior Advisor, Eric Gordon, Ph.D.

Redwood City, CA – June 14, 2016 – REVOLUTION Medicines, Inc., a company focused on the discovery and development of innovative drugs inspired by natural products, today announced that noted chemical biologist…

Read more

News

Cover Story: 10 Start-Ups To Watch - Revolution Medicines

Mother Nature is a master chemist. More than half of the pharmacopoeia starts with a compound generated by her hands. But there’s a catch: The complexity of natural products can make them tough—sometimes impossible—to re-create in a lab, let…

Read more

News

Revolution Medicines - 2015 Fierce 15

The scoop: As drug discovery platforms go, none is older than evolution. Over billions of years, the slow march of life has brought about natural agents gradually selected for their ability to modulate certain biological…

Read more

Press Release

FierceBiotech Names Revolution Medicines as a “Fierce 15” Biotech Company of 2015

Redwood City, CA – September 30, 2015 – REVOLUTION Medicines, Inc., a company focused on the discovery and development of innovative drugs derived from natural compounds, today announced that it has been named by FierceBiotech as…

Read more

Press Release

Rationally Designed Antifungal Compounds that Evade Resistance Reported in Nature Chemical Biology by Scientific Founder of Revolution Medicines

Redwood City, Calif., June 1, 2015 – REVOLUTION Medicines, Inc., a company focused on the discovery and development of innovative drugs derived from natural compounds, announced that progress in antimicrobial drug discovery was…

Read more

Press Release

Revolution Medicines Appoints Pharmaceutical Commercial Executive Elizabeth McKee Anderson to Board of Directors

San Francisco/Redwood City, Calif., April 9, 2015 – REVOLUTION Medicines, Inc., a company focused on the discovery and development of innovative drugs derived by redesigning natural compounds, today announced the…

Read more

Press Release

Major Advances in Synthetic Chemistry Reported in Science by Founding Scientist of Revolution Medicines

Redwood City, Calif., March 12, 2015 – REVOLUTION Medicines, Inc., a company focused on the discovery and development of innovative drugs derived from natural compounds, today announced the publication of new research by the…

Read more

Press Release

Revolution Medicines Expands Executive Leadership Team

San Francisco/Redwood City, Calif., March 5, 2015 – REVOLUTION Medicines, Inc., a company focused on the discovery and development of innovative drugs derived from natural compounds, today announced the appointment of two senior…

Read more

Press Release

Third Rock Ventures Launches Revolution Medicines with $45 Million Series A to Redesign Evolution’s Products to Treat Serious Diseases

San Francisco/Redwood City, Calif. – February 4, 2015 – Third Rock Ventures, LLC today announced the formation of REVOLUTION Medicines, Inc. with a $45 million Series A financing to…

Read more